MCP-1 Induces activation of map-kinases ERK, JNK, and p38 MAPK in human endothelial cells  by Werle, Martina et al.
JACC 
1179-81 Computerized Community Cholesterol Control (4C) 
Harel Gilutz. Julian Zelingher, Yaakov Henkin, Dan Y. Bonneh, Zvi Liss, Roni Peleg, Max 
Mayslus, Reuben Ilia, Avi Porath, Soroka Medical Center, Beer Sheva, Israel, Faculty of 
Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel. 
Introduction: The majority of patients with coronary artery disease (CAD) are eligible for 
lipid-lowering drugs, yet most of them are sub-optimally managed. A Community Health 
information Network integrated with Computer-based Clinical Decision Support Systems 
is an effective communication modality to facilitated guideline implementation. 
Objeetlves: To study the impact of "smart CHIN - CDSS communicator" in CAD for sec- 
ondary prevention. 
Methods: Patients were from 113 demographically-matched clinics, 55 clinics in the 
intervention group, and 57 clinics following routine practice (control). We developed a 
computerized engine that incorporates computerized atabases and creates a compre- 
hensive prospective registry including demographics, diagnosis, laboratory results and 
medication. This system detected patients requiring screening and who were eligible for 
lipid lowering drugs, then mailed automatic remainders to the primary medical teams in 
the intervention group clinics recommending screening or medium dose of statins. Peri- 
odic reinforcement of reminding is performed every 4 months. 
Results: Out of 2528 patients with CAD who were enrolled, by August 2001, 1558 had 
been followed for 4 months. Those in an intervention group clinic demonstrated an 
improved lipid profile screening (65% vs 50%) (p<0.01), and a higher percent of patients 
achieved target levels (21% vs 13%) (p<0.00Ol). 
Conclualons: A computerized automatic reminder generator was shown to have a sig- 
nificantly positive short- term effect on use and results of secondary prevention mea- 
sures. This intervention is expected to have a major impact on the clinical course of CAD 
disease. Clinical evaluation of cardiac event reduction will take place in January 2002, 
after one year of follow-up. 
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2:00 p.m. 
860-1 Activated Monocytes Induce Smooth Muscle Cell 
Apoptosis: Role of the FasLigand/Fas Death Receptor 
Pathway 
Saniav S. Vasudevan, Puvi N. Seshiah, Neuza Lopes, Tao Wang, Chunming Dong, 
Pascal J. Goldschmidt-Clermont, Duke University Medical Center, Durham, North 
Carolina. 
Background: Plaque instability and rupture are central features of atherothrombotic syn- 
dromes. Vulnerable plaques have a decreased number of vascular smooth muscle cells 
(VSMC), a rudimentary extracallular matrix protein content and an increased number of 
monocytes/macrophages (MM), in their fibrous caps. We have shown that VSMC death 
is clue to interaction of these cells with MM activated by M-CSF. Furthermore, such 
VSMC killing by MM requires the tight binding of MM to VSMC mediated by CD11b- 
CD18. We hypothesized that, once tightly bound to VSMC, MM kill VSMC by activating 
their Fas death pathway, thus leading to apoptosis of VSMC. 
Methods: FasL and Fas expression were studied on VSMC and MM co-cultured for 
72hours, in the presence of M-CSF (100ng/ml). Monocytes were identified by CD14- 
FITC staining. Similar experiments were conducted using a Fas-Fc fusion protein that 
inhibits FasL/Fas mediated apoptosis. 
Results: As shown previously, apoptosis of VSMC was induced by MM, but only in the 
presence of M-CSF (57.8_+ 0.8%). We used a pan-caspase inhibitor (ZVAD fmk) to show 
that death of VSMC induced by M-CSF-ectivated MM was indeed by apoptosis. When 
VSMC were pre-incubated with ZVAD fmk (10kLM/ml), apoptosis induced by M-CSF acti- 
vated MM was completely abrogated (15.4_+0.4%), and similar to control VSMC with 
monocytes depdved of M-CSF (12.2_+1.6%). Next, we tested the role of Fas/Fas-ligand in 
the apoptotic death of VSMC induced by M-CSF-activated MM. Fas expression was 
detected only on VSMC and not the surface of MM. Fas-L was detected on MM. VSMC 
apoptosis triggered by M-CSF-activated MM was nearly completely prevented when co- 
cultures were treated with huReFas-Fc fusion protein (2~g/ml) (27.0i-_ 1.0%, p<O.O05 vs. 
identical conditions, except for the omission of huReFas-Fc). This apoptotic index was 
not different from that seen in control VSMC with unactivated MM (15.7+ 3.5%, p_<O.06) 
(with or without huReFas-Fc, 2pg/ml). 
Conclusions: This data suggests a mechanism for plaque destabilization and rupture 
where VSMC death induced by M-CSF-activatad MM is by apoptosis and the FasL/Fas 
death receptor pathway could play a major role in this process. 
2:15 p.m. 
860-2 IL-12 Mediated Activation of Cytotoxic CD4 T Cells in 
Acute Coronary Syndromes 
Takako NakaJima, Amr E. Abbas, Stephanie Schultz, Kenneth J. Wardngton, Stephen L. 
Kopecky, Robed L. Frye, Jorg J. Goronzy, Cornelia M. Weyand, Mayo Clinic, Rochester, 
Minnesota. 
Background: The inflammatory infiltrate in unstable plaque is unusual in that it contains 
a specialized subset of clonally expanded CD4+ T calls that lack the CD28 molecule. The 
functional profile and the signals required to activate CD4+CD28- T calls in the plaque 
are not known. 
Methods: CD4+CD28-T cell clones (n=60) were isolated from 3 patients with plaque 
instability and subjected to gene profiling. Selective expression of genes was confirmed 
by PCR and FACS analysis and gene products of interest were further analysed on 
freshly harvested peripheral blood lymphocytes. Functional activities of T cell clones 
were examined in cytotoxicity assays on endothelial target cells. 
Results: CD4+CD28- T cell clones were distinct from classical CD4+CD28+ T cells in 
that they possessed a cytolytic machinery and killed endothelial cells. They also overex- 
pressed CD161, a C type lectin typically found on NK cells where it amplifies cytotoxic 
function. Frequencies of CD4+CD161+ T ceils were twofold increased in the blood of 
patients with unstable angina (17.6 %) as compared to stable angina (9.8 %, p<0.003) 
and matched controls (7.9 %, p=<0.001). We hypothesized that the appearance of 
CD161 on CD4 T cells was a consequence of recent activation and explored the ability of 
pro-inflammatory cytokines (IL-2, IL-12, IL-15, and IL-18) to upregulate CD161. Culture 
of CD4+CD28- but not CD4+CD28+ T cell clones in IL-12 promptly induced CD161 on 
the surface, even in the absence of T cel~ receptor crosslinking. 
Conclusions: Patients with ACS have T cells that can be activated in response to IL-12 
without he need for antigen recognition. The accumulation of CD4+CD161+ cells in the 
circulation of these patients indicates that a marked proportion of their T cells are consti- 
tutively activated, likely by the exposure to the pro-inflammatory cytokine IL-12. Expres- 
sion of the lectin CD161 prepares these T cells for rapid transmigration through 
endothelial cells, preferred recruitment into tissue lesions and accelerated cytotoxicity. 
2:30 p.m. 
860-3 Monocyte Chemotactic Protein 1 Ampli f ies Serotonln- 
Induced Vascular Smooth Muscle Cell Prol iferation 
Takuva Watanabe, Takashi Katagiri, Rajbabu Pakala, Claude R. Benedict, Third 
Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan, 
Division of Cardiology, University of Texas-Houston Health Science Center, Houston, 
Texas. 
Background: Monocyte chemotactic protein 1 (MCP-1), which is synthesized by vascular 
cells, is a chemoattractant for monocytes and has been implicated in a wide range of 
acute and chronic inflammatory processes characterized by monocyte infiltration, includ- 
ing atheresclerosis. However, it is unclear whether MCP-1 is able to modulate vascular 
smooth muscle cell (VSMC) proliferation. We assessed the effect of MCP-1 on VSMC 
proliferation and its interaction with serotonin (5-HT), a mitogen for VSMCs. 
Methods: Growth-arrested VSMCs were stimulated with different concentrations of MCP- 
1 (25-200 ng/ml) and 5-HT (5 and 50 microM) in serum-free medium. DNA synthesis in 
VSMCs was measured by [3H]thymidine incorporation. 
Results: 5-HT at a concentration of 5 or 50 microM significantly stimulated DNA Synthe- 
sis by 1.8- or 2.1-fold over the control value, respectively (p < 0.0001 ). However, MCP-1 
at concentrations tested did not have any significant effect on DNA synthesis. Even 
though MCP-1 (50 ng/ml) by itself is not mitogenic, when added to 5-HT, it significantly 
amplified the mitogenic effect of 5-HT compared with that of 5-HT alone (p < 0.0001). 
The 5-HT2A receptor antagonist serpogrelate (10 microM) and its major metabolits M-1 
(0.1 microM), pertussis toxin (10 ng/ml), Src family protein tyresine kinase (PTK) inhibitor 
PP2 (1 microM), protein kinase C (PKC) inhibitor Ro31-8220 (0.1 microM), and MAPK 
kinase inhibitor PD098059 (10 microM) significantly inhibited the mifogenic effect of 5-HT 
and its interaction with MCP-I. Anti-MCP-I antibody (2 microg/ml) and the JAK2 inhibitor 
AG490 (10 microM) significantly inhibited the interaction of MCP-1 with 5-HT. Further, the 
amplified mitogenic effect of 5-HT with MCP-1 was completely reversed by the combined 
use of serpogrelate with anti-MCP-1 antibody. 
Conclusions: Our results suggest that MCP-1 amplifies the mitogenic effect of 5-HT on 
VSMCs. The mitogenic effect of 5-HT may be mediated by the G protein-Src family PTK- 
PKC-MAPK pathway. The activation of JAK2/STAT3 pathway by MCP-1 in addition to the 
MAPK pathway by 5-HT may explain the potentiating effect of MCP-1 on 5-HT-induced 
mitogenesis. 
2:45 p.m. 
860-4 MCP-f Induces Activation of MAP-Kinaaes ERK, JNK, 
and p38 MAPK in Human Endothelial Cells 
Martina Werle. Katherina Hanna, Joerg Kreuzer, Department of Cardiology, University of 
Heidelberg, Heidelberg, Germany. 
Background: Activation of vascular endothelial cells (EC) plays an important pathogenic 
role in the development of atherosclerosis. Monocyte chemoattractant protein-1 (MCP-1) 
is a potent chemoattractant of monocytes. Besides induction of monocyte recruitment, it
has been suggested that MCP-1 can also affect cellular responses of EC. 
Methods: We now investigated whether MCP-1 activated the three major mitogen acti- 
vated protein (MAP)-kinases extracellular signal-regulated kinase (ERK), c-Jun amino 
terminal kinase (JNK) and p38 MAPK. 
Results: Stimulation of EC with MCP-t induced a time-dependent activation of all three 
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MAP-kinases. As evidenced by ERK phosphorylation, concentrations as low as 0.1 ng/ml 
were sufficient for this mechanism. Pretreatment with pertussis toxin (PTX) inhibited 
MCP-l-dependent ERK phosphoryletion. MCP-1 also induced secretion of matrix metal- 
Iopreteinase (MMP)-2 which along with ERK activation was inhibited by PD98059. 
Conclusion: The results demonstrate that MCP-1 can lead to direct activation of MAP 
kinases together with induction of MMPs in EC. Our data thus propose a new mechanism 
for the proatherogenic effect of MCP-1, 
3:00 p.m. 
880-5 Product ion  of  MCP-1 by Human Aortic Endothelial 
Cells, Upon Depletion of Nutrients, Requires Rac 1 
Neuza H. LoDes, Sanjay S. Vasudevan, Herve Kovacic, Pascal J. Goldschmidt-Clermont, 
Duke University Medical Center, Durham, North Carolina, Universite the La 
mediterrsnee, Marseille, France. 
Background: Following an episode of coronary occlusion, inflammatory cells accumu- 
late within small vessels of the coronary tree, and contribute to the injury that damages 
the myooardium. The chemokine monocyte chemoattractant protein-1 (MCP-1) is a key 
regulator of leukocyte recruitment o sites of inflammation. However, the exact molecular 
mechanism involved in controlling expression of MCP-1 in ischemic conditions remains 
unclear. The small GTP-binding protein Racl regulates the production of reactive oxygen 
species (ROS) by ubiquitous NADPH oxidase complex, the major source of superoxide 
in most cells. We investigated the effect of nutrient depletion, a condition associated with 
ischemia, on MCP-1 production in human aortic endothelial cells (HAEC) and the role of 
Rac-1 and reactive oxygen species in this process. Method==: Recombinant adenovi- 
ruses, for expression of either dominant negative (Racl-N17) or constitutively active 
(Racl-V12) mutants of Recl, geranylgeranyltransferase inhibitor GGTI-298 (10uM), or 
N-acetylcysteine (20mM) were used to study the role of Racl and ROS in MCP-1 
expression. Nutrient depletion (ND) was obtained by shifting HAEC from 10% to 0.5% 
FBS. MCP-1 production was measured by ELISA. Results: Nutrient depletion increased 
MCP-1 production by HAEC (4.8+/-0.66 fold, p<0.01), in a time dependent manner peak- 
ing at 24 hours. Expression of Rac1-V12 increased MCP-1 expression to a similar level, 
even in the absence of NP. Transduction of HAEC with Recl-N17 at 25 MOI decreased 
NP-induced MCP-t production (p=0.007). Likewise, NAC and GGTI-298, both decreased 
MCP-1 production (p<0.05 and p<0.001, respectively). Conclusion: These results sug- 
gest that nutrient depletion associated with ischemia is sufficient to induce MCP-1 pro- 
duction by HAEC, and that such production requires a functional Racl, redox-sensitive, 
pathway. 
3:15 p.m. 
860-6 Motexafin Lutetium Phototherapy Induces Apoptoaie in 
Macrophages and Downregulates Monocyte 
Chemosttractant Protein Expression In Human 
Coronary Artery Smooth Muscle Cel ls  
Kathryn W. Woodburn, Yu Luo, Krishnankuttv Sudhir, Pharmacyclics, Sunnyvale, 
California. 
Background: Macrephage burden has been shown to be a main predictor for restenosis 
after percutaneous interventions. Monocyte chemoattractant protein (MCP-1) is a 
chemokine that is produced by stimulated endothelial cells and smooth muscle cells 
(SMCs), and is responsible for recruiting monooytes/macrophages into injured arterial 
walls. Motexafin lutetium (MLu), a photosensitizer, has been shown to reduce macroph- 
age burden in experimental models. The mechanism by which MLu phototherapy 
reduces macrophages and the impact that phototherapy has on MCP-1 production was 
evaluated. Methods: The subcellular localization of MLu was evaluated in human THP-1 
macrophages (ATCC) and coronary artery SMCs (Clonetios). Co-labeling studies were 
performed using organelle specific fluorogenic probes. After phototherapy; changes in 
nuclear morphology were assessed with Hoeshst 33342 staining; lysosomal integrity was 
evaluated using fluorescence after acridine orange staining; cytochrome C and cathepsin 
B distribution were ascertained using immunofiuorescence. Cellular viability experiments 
were performed with an M'l-I" (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrezolium bro-
mide) assay. RNA was harvested from SMCs for measurement of MCP-1 mRNA levels 
with the RibcQuant TM multi-probe RNase protection assay system (PharMingen), 
Results: MLu partitioned within macrophages and SMC lysosomes, Photosensitization 
led to lysosomal instability, release of intralysosomal cathepsin B into the cytoplasm, and 
the subsequent release of cytochrome C from the mitochondria. Chromatin condensation 
and nuclear blebbing, hallmark features of apoptosis, ensued. Photosensitization also 
caused downregulafion of MCP-1 in human coronary artery SMCs. Conclusions: Con- 
sidering the crucial and pivotal role that MCP-1 has in plaque progression, stabilization 
and in restenosis, it is likely that one of the mechanisms by which MLu-mediated photo- 
therapy exerts its effect on plaque resolution is through the apoptotic elimination of mac- 
rephages and via the downregulation of MCP-1 production. 
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863 Vascular Disease Insights: Registry, 
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Georgia World Congress Center, Room 254W 
2:00 p.m. 
863-1 New Classification of  Aort ic  D issect ion With Improved 
Impact on Prognosis 
Barbara M. Richartz. Dean E. Smith, Jeanna V. Cooper, Rajendra M. Mehta, Kim A. 
Eagle, Christoph A. Nienaber, on Behaff of International Registry of Acute Aortic 
Dissection (IRAD) Investigators, Ann Arbor, Michigan. 
Background: The entry site location is currently used to classify and stratify acute aortic 
dissection. Type A lesions require urgent surgical therapy to improve survival, while type 
B lesions often have a better outcome and benefit from stenting or medical management. 
In the attempt to use anatomic information for assessment of prognosis we correlated the 
entry site location of type A and B aortic dissection with 30-day-mortality. 
Methods: 820 patients with acute aortic dissection were enrolled in the database of the 
International Registry of Acute Aortic Dissection (IRAD). According to exact entry site 
location from diagnostic imaging we established 6 subgroups: aortic root (n = 197, 25%), 
ascending aorta (n = 291,36%), arch (n = 59, 9%), left subclavian area (n = 157, 19%), 
descending thoracic aorta (n = 85, 10%), and abdominal aorta (n = 21, < 1%) and deter- 
mined 30-day-mortality in each group, 
Results: Among type A aortic dissections significant differences in 30-day-mortality were 
found with a death rate of 37% in aortic root, 28% in ascending aorta, and 23% in the 
arch [p < 0.001]. Conversely, in type B aodic dissection modality did not differ between 
entry sites at left subclavian area (12%), descending thoracic aorta (13%), and abdomi- 
nal aorta (10%). Demographic data were similar in all groups. 
Conclusions: The closer the distance between entry site location and aortic root, the 
worse the prognosis of type A aodic dissection. Thus, prognosis in type A dissection is 
diverse and can be subclassified into 3 groups. Conversely, type B aortic dissection is 
homogeneous with respect to prognosis and subclassification is only descriptive. 
2:15 p.rn, 
863-2 Familial Aortic Dissection/Aneurysm Associated With 
Patent Ductus Arteriosus: A New Entity? 
Philieoa Khau Van Kien. Alain Lalande, Caroline Bonnet, Arnaud Delfinger, Annie Petit, 
Anne Nivelon-Chevallier, Fran~:ois Brunette, Xavier Jeunemaitre, Jean-Eric Wolf, CHU 
Becage, Dijon, France. 
Background: In March 2001, a first report from United States described an unusual family 
in which 5 members present a combination of thoracic aortic dissestion/aneurysm (TAD/ 
TAA) and patent ductus artedosus (PDA). The authors suggested a possible common 
genetic defects. We report a large French family with the same association. 
Subjects and methods: this family composed of 179 members was ascertained from a 
single probant. Forty first-degree relative subjects from three different generations have 
been enrolled in a ctinical investigation protocol composed of two pads: 
- a medical questionnaire concerning available medical records, state of health and 
allowing to investigate the familial history. A standardized clinical examination focused on 
classical signs of Marfan and Ehlers-Danlos syndromes. 
- An annual Iong-tarm follow-up based on: standardized cardiovascular examination, 
transthoracic echocardiography and a thoracic MRI, completed by transesophageal ultra- 
sonography when necessary, allowing the accurate measurement of the aorta, great ves- 
sels and heart. At the time of the inclusion, blood measurements of total and LDL-HDL 
cholesterol, triglycerides and glucose were performed 
Results: 9 cases of TAD and TAA among this family 4 TAD (2 males and 2 females) and 
5 TAA (4 males and 1 female). All the cases of TAA have been discovered in asymptom- 
atic subjects by screening. 8 cases of PDA without any particular neonatal context. 5 
cases of cerebral stroke with two of them due to a documented intracranian carotidian 
aneurysm, 3 cases of suspicious sudden death. All theses vascular findings cosegrege 
with cases of TAA/TAD in an autosomal dominant with incomplete penetrance pattern of 
inheritance. For all the probants there are no arguments for Marfan syndrome or Ehlers- 
Danlos syndrome vascular type. There is no particular familial context of arterial hyper- 
tension or atheresclerosis. 
According to both families, aortic dissection/aneurysm with patent ductus artedosus may 
be a new entity due to a common genetic defect that remains to be identified. FamUial 
screening is very important in such a family that is still seldom recognized. 
2:30 p.m. 
